Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 3, 2016, Pages 576-580

  Van Veluw, Susanne J ^a,b   Biessels, Geert Jan ^a   Bouvy, Willem H ^a   Spliet, Wim G M ^a   Zwanenburg, Jaco J M ^a   Luijten, Peter R ^a   Macklin, Eric A ^c   Rozemuller, Annemieke J M ^a   Gurol, M Edip ^b   Greenberg, Steven M ^b   Viswanathan, Anand ^b   Martinez Ramirez, Sergi ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

7 T magnetic resonance imaging; amyloid angiopathy; histology; microbleeds; perivascular spaces

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; ARTICLE; AUTOPSY; BRAIN BLOOD VESSEL; BRAIN CORTEX; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; JUXTACORTICAL PERIVASCULAR SPACES; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PERIVASCULAR SPACE; PRIORITY JOURNAL; TISSUE SECTION; VASCULAR AMYLOIDOSIS; VASODILATATION; PATHOLOGY; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL CORTEX; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84959351760     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15620434     Document Type: Article

References (10)

1. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease, and its contribution to ageing, and neurodegeneration. Lancet Neurol 2013; 12: 822-838
2. Carare RO, Bernardes-Silva M, Newman TA, et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries, and arteries: significance for cerebral amyloid angiopathy, and neuroimmunology. Neuropathol Appl Neurobiol 2008; 34: 131-144
3. Weller RO, Boche D, and Nicoll JA. Microvasculature changes, and cerebral amyloid angiopathy in Alzheimers disease, and their potential impact on therapy. Acta Neuropathol 2009; 118: 87-102
4. Roher AE, Kuo YM, Esh C, et al. Cortical, and leptomeningeal cerebrovascular amyloid, and white matter pathology in Alzheimers disease. Mol Med 2003; 9: 112-122
5. Charidimou A, Meegahage R, Fox Z, et al. Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J Neurol Neurosurg Psychiatry 2013; 84: 624-629
6. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology 2013; 80: 1551-1556
7. Charidimou A, Hong YT, Jäger HR, et al. White matter perivascular spaces on magnetic resonance imaging: marker of cerebrovascular amyloid burden?. Stroke 2015; 46: 1707-1709
8. Love S, Chalmers K, Ince P, et al. Development, appraisal, validation, and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 2014; 3: 19-32
9. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311-324
10. Charidimou A, Martinez-Ramirez S, Shoamanesh A, et al. Cerebral amyloid angiopathy with, and without hemorrhage: evidence of different disease phenotypes. Neurology 2015; 84: 1206-1212